SE385893B - Sett att framstella diakylxantin-derivat - Google Patents

Sett att framstella diakylxantin-derivat

Info

Publication number
SE385893B
SE385893B SE7003922A SE392270A SE385893B SE 385893 B SE385893 B SE 385893B SE 7003922 A SE7003922 A SE 7003922A SE 392270 A SE392270 A SE 392270A SE 385893 B SE385893 B SE 385893B
Authority
SE
Sweden
Prior art keywords
diacylxantine
derivatives
preparing
preparing diacylxantine
diacylxantine derivatives
Prior art date
Application number
SE7003922A
Other languages
English (en)
Swedish (sv)
Inventor
W Bestian
Original Assignee
W Bestian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1915979A external-priority patent/DE1915979C3/de
Application filed by W Bestian filed Critical W Bestian
Publication of SE385893B publication Critical patent/SE385893B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7003922A 1969-03-28 1970-03-23 Sett att framstella diakylxantin-derivat SE385893B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1915979A DE1915979C3 (de) 1969-03-20 1969-03-28 1,3-Dimethyl-xanthin-Derivate und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
SE385893B true SE385893B (sv) 1976-07-26

Family

ID=5729638

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7003922A SE385893B (sv) 1969-03-28 1970-03-23 Sett att framstella diakylxantin-derivat

Country Status (14)

Country Link
US (1) US3734911A (es)
JP (1) JPS5417757B1 (es)
AT (2) AT309463B (es)
BE (1) BE748165A (es)
BR (1) BR7018080D0 (es)
CA (1) CA932730A (es)
CH (1) CH528529A (es)
DK (1) DK127101B (es)
ES (1) ES377662A1 (es)
FR (1) FR2035966B1 (es)
GB (1) GB1289287A (es)
NL (1) NL7004161A (es)
NO (1) NO127618B (es)
SE (1) SE385893B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374835A (en) * 1980-01-31 1983-02-22 Laroche-Navarron, S.A. Piperazine derivatives of theophylline
IT1195267B (it) * 1980-04-15 1988-10-12 Abc Ist Biolog Chem Spa Derivati teofillinmetildiossolanici,procedimento per la loro preparazione e relative composizioni farmaceutiche
CH648559A5 (de) * 1981-07-20 1985-03-29 Siegfried Ag Theophyllinderivate und verfahren zu deren herstellung.
US4400381A (en) * 1981-07-31 1983-08-23 Laroche-Navarron, S.A. Piperazine derivatives of theophylline
US4374837A (en) * 1981-07-31 1983-02-22 Laroche Navarron, S.A. Piperazine derivatives of theobromine
US5021574A (en) * 1988-03-03 1991-06-04 Ortho Pharmaceutical Corporation 6-substituted purinyl piperazine derivatives
US5164390A (en) * 1988-03-03 1992-11-17 Ortho Pharmaceutical Corporation 6-substituted purinyl piperazine derivatives
US4876257A (en) * 1988-03-03 1989-10-24 Ortho Pharmaceutical Corporation 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents
EP0468065B1 (de) * 1990-07-23 1994-01-05 Siemens Aktiengesellschaft Staubsauger mit einer in seinen Staubraum einsetzbaren Filterkassette
WO1995022546A1 (en) * 1994-02-18 1995-08-24 Cell Therapeutics, Inc. Intracellular signalling mediators
US7865927B2 (en) 2006-09-11 2011-01-04 Apple Inc. Enhancing media system metadata

Also Published As

Publication number Publication date
JPS5417757B1 (es) 1979-07-02
ES377662A1 (es) 1973-01-01
DK127101B (da) 1973-09-24
US3734911A (en) 1973-05-22
CA932730A (en) 1973-08-28
NL7004161A (es) 1970-09-30
BE748165A (fr) 1970-09-28
CH528529A (de) 1972-09-30
GB1289287A (es) 1972-09-13
NO127618B (es) 1973-07-23
FR2035966A1 (es) 1970-12-24
FR2035966B1 (es) 1974-10-11
BR7018080D0 (pt) 1973-04-26
AT309463B (de) 1973-08-27
AT317249B (de) 1974-08-26

Similar Documents

Publication Publication Date Title
SE390736B (sv) Forfarande for framstellning av maltos
BG18599A3 (bg) Метод за получаване на бета-арил-2-аминоалкоксистироли
BG17795A3 (bg) Метод за получаване на субституирани с арилпиперазинилалкил- аминоурацили-урацилетери-урацилитиоктер
BG17749A3 (bg) Метод за получаване на фенокси-2-хидрокси -3- циклоалкиламинопропани
SE402123B (sv) Sett att framstella 7-amino-3-metylcefemforeningar
SE398880B (sv) Sett att framstella basiskt substituerade 3-bensoyl-bensofuranderivat
SU505349A3 (ru) Способ получени нафтилалкиламинов
SE402287B (sv) Sett att framstella indazol-3-karboxamider
SE385893B (sv) Sett att framstella diakylxantin-derivat
SE382212B (sv) Sett att framstella dekahydroisokinolinderivat
SE385707B (sv) Sett att framstella 8,9-didehydro-10-alkoxi-ergolenderivat
BG17579A3 (bg) Метод за получаване на имидазолиди - нови производни
SE397190B (sv) Sett att framstella substituerade dibensocykloheptener
BG17802A3 (bg) Метод за получаване на диалиламиноалканоиламиди
SU439969A3 (ru) Способ получения замещенной бензолсульфонилмочевины
SE382063B (sv) Sett att framstella fenyl-vinylfosfonsyraderivat
SE380261B (sv) Sett att framstella n-bensoyl-2-alkyl-3-indolyl-ettiksyra och derivat derav
BG17773A3 (bg) Метод за получаване на аминоалкилпиролидини
SE390301B (sv) Sett att framstella butyrfenonederivat
BG16333A3 (bg) Метод за получаване на гама-цианбутиралдимини
SE396219B (sv) Sett att framstella pyridyl-piperazinderivat
SE394669B (sv) Sett att framstella 4-hydroxifenylglycin
SE396383B (sv) Sett att framstella fenylbutanoliderivat
SE7513236L (sv) Sett att framstella furfurylidenhydrazinderivat
SE384854B (sv) Sett att framstella 1-bensoyloxi-2-lagalylaminobensocykloalkanderivat